Company intelligence / Profile preview
MEDIFIC
Hwaseong-si, Gyeonggi-do, South Koreamedific.co.kr ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
MEDIFIC has not yet entered clinical trials but has developed preclinical programs focused on first-in-class anti-cancer drugs targeting CSCs and undruggable proteins. The company uses in vivo models such as GBM orthotopic xenograft mouse models for efficacy validation. It has received support from the Korea Drug Development Fund and the Ministry of SMEs and Startups of Korea for non-clinical development projects.
No published clinical results as of May 2025.
- Therapeutic areas
- OncologyMetabolic Disorders
- Modalities
- Small molecules (for undruggable targets and cancer stem cells)Exosome-based immunotherapy
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Joint research contracts with Korea University, Seoul National University,
Chungbuk National University; MOU with KMEDI hub.
Beyond the preview
Go deeper on MEDIFIC.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MEDIFIC.